Fazadinium bromide

Fazadinium bromide
Clinical data
Trade names	Fazadon
ATC code	M03AC08 (WHO) ;
Identifiers
	IUPAC name (E)-bis(3-methyl-2-phenylimidazo[3,2-a]; pyridin-4-ium-1-yl)diazene dibromide;
CAS Number	49564-56-9 ;
PubChem CID	6321422;
ChemSpider	21161354 ;
UNII	8WV5538LFK;
KEGG	D07273 ;
CompTox Dashboard (EPA)	DTXSID4023040 ;
ECHA InfoCard	100.051.236
Chemical and physical data
Formula	C28H24Br2N6
Molar mass	604.350 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES Cc1c(n(c2[n+]1cccc2)N=Nn3c4cccc[n+]4c(c3c5ccccc5)C)c6ccccc6.[Br-].[Br-];
	InChI InChI=1S/C28H24N6.2BrH/c1-21-27(23-13-5-3-6-14-23)33(25-17-9-11-19-31(21)25)29-30-34-26-18-10-12-20-32(26)22(2)28(34)24-15-7-4-8-16-24;;/h3-20H,1-2H3;2*1H/q+2;;/p-2 ; Key:LBOZSXSPRGACHC-UHFFFAOYSA-L ;
	(what is this?) (verify)

Fazadinium bromide is a muscle relaxant which acts as a nicotinic acetylcholine receptor antagonist through neuromuscular blockade.^[1]

References

^ Camu F, D'Hollander A (1978). "Neuromuscular blockade of fazadinium bromide (AH 8165) in renal failure patients". Acta Anaesthesiologica Scandinavica. 22 (3): 221–6. doi:10.1111/aas.1978.22.3.221. PMID 27936.

This drug article relating to the musculoskeletal system is a stub. You can help Wikipedia by expanding it.